4//SEC Filing
Foley Todd 4
Accession 0001415889-25-011574
CIK 0001785530other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 4:17 PM ET
Size
21.5 KB
Accession
0001415889-25-011574
Insider Transaction Report
Form 4
MPM BioVentures 2014, L.P.
10% Owner
Transactions
- Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−4,015→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-04-09→ Common Stock (4,015 underlying) - Exercise of In-Money
Common Stock
2025-03-27$0.09/sh+22,758$2,048→ 3,210,756 total(indirect: See Footnote) - Sale
Common Stock
2025-03-27$1.05/sh−1,963$2,061→ 3,208,793 total(indirect: See Footnote) - Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−18,743→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-08-13→ Common Stock (18,743 underlying)
MPM BioVentures 2014 LLC
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2025-03-27$0.09/sh+22,758$2,048→ 3,210,756 total(indirect: See Footnote) - Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−4,015→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-04-09→ Common Stock (4,015 underlying) - Sale
Common Stock
2025-03-27$1.05/sh−1,963$2,061→ 3,208,793 total(indirect: See Footnote) - Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−18,743→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-08-13→ Common Stock (18,743 underlying)
MPM BioVentures 2014 GP LLC
10% Owner
Transactions
- Sale
Common Stock
2025-03-27$1.05/sh−1,963$2,061→ 3,208,793 total(indirect: See Footnote) - Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−18,743→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-08-13→ Common Stock (18,743 underlying) - Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−4,015→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-04-09→ Common Stock (4,015 underlying) - Exercise of In-Money
Common Stock
2025-03-27$0.09/sh+22,758$2,048→ 3,210,756 total(indirect: See Footnote)
Foley Todd
10% Owner
Transactions
- Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−4,015→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-04-09→ Common Stock (4,015 underlying) - Sale
Common Stock
2025-03-27$1.05/sh−1,963$2,061→ 3,208,793 total(indirect: See Footnote) - Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−18,743→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-08-13→ Common Stock (18,743 underlying) - Exercise of In-Money
Common Stock
2025-03-27$0.09/sh+22,758$2,048→ 3,210,756 total(indirect: See Footnote)
MPM BioVentures 2014 (B), L.P.
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2025-03-27$0.09/sh+22,758$2,048→ 3,210,756 total(indirect: See Footnote) - Sale
Common Stock
2025-03-27$1.05/sh−1,963$2,061→ 3,208,793 total(indirect: See Footnote) - Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−4,015→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-04-09→ Common Stock (4,015 underlying) - Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−18,743→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-08-13→ Common Stock (18,743 underlying)
Transactions
- Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−18,743→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-08-13→ Common Stock (18,743 underlying) - Exercise of In-Money
Common Stock
2025-03-27$0.09/sh+22,758$2,048→ 3,210,756 total(indirect: See Footnote) - Sale
Common Stock
2025-03-27$1.05/sh−1,963$2,061→ 3,208,793 total(indirect: See Footnote) - Exercise of In-Money
Warrant (Right to Buy)
2025-03-27−4,015→ 0 total(indirect: See Footnote)Exercise: $0.09Exp: 2025-04-09→ Common Stock (4,015 underlying)
Footnotes (6)
- [F1]On March 27, 2025, the Reporting Persons exercised warrants to purchase an aggregate of 22,758 shares of the Company's Common Stock for $0.09 per share. The Reporting Persons paid the exercise price on a cashless basis, resulting in the Company's withholding of 1,963 of the warrant shares to pay the exercise price and issuing the remaining 20,795 shares.
- [F2]The shares are held as follows: 2,915,905 by MPM BioVentures 2014, L.P. ("BV 2014"), 194,486 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)") and 100,365 by MPM Asset Management Investors BV2014 LLC ("AM BV2014"). MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). BV LLC is the manager of AM BV2014.Todd Foley is a Managing Director of BV LLC. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.
- [F3]The shares are held as follows: 2,914,123 by BV 2014, 194,367 by MPM 2014(B) and 100,303 by AM BV2014. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.
- [F4]Immediately exercisable.
- [F5]The warrants were held as follows: 3,647 by BV 2014, 243 by BV 2014(B) and 125 by AM BV 2014.
- [F6]The warrants were held as follows: 17,023 by BV 2014, 1,135 by BV 2014(B) and 585 by AM BV 2014.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001473930
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 4:17 PM ET
- Size
- 21.5 KB